Number of the records: 1
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy
- 1.BUBENÍK, Jan, ŠÍMOVÁ, Jana. Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy. Journal of Balkan Union of Oncology. 2009, 14(1), 169-173. ISSN 1107-0625. E-ISSN 2241-6293.
Number of the records: 1